{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:15:16Z","timestamp":1780992916983,"version":"3.54.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>In 2021, Qatar experienced considerable incidence of SARS-CoV-2 infection that was dominated sequentially by the Alpha, Beta, and Delta variants. Using the cycle threshold (Ct) value of an RT-qPCR-positive test to proxy the inverse of infectiousness, we investigated infectiousness of SARS-CoV-2 infections by variant, age, sex, vaccination status, prior infection status, and reason for testing in a random sample of 18,355 RT-qPCR-genotyped infections. Regression analyses were conducted to estimate associations with the Ct value of RT-qPCR-positive tests. Compared to Beta infections, Alpha and Delta infections demonstrated 2.56 higher Ct cycles (95% CI: 2.35-2.78), and 4.92 fewer cycles (95% CI: 4.67- 5.16), respectively. The Ct value declined gradually with age and was especially high for children &amp;lt;10 years of age, signifying lower infectiousness in small children. Children &amp;lt;10 years of age had 2.18 higher Ct cycles (95% CI: 1.88-2.48) than those 10-19 years of age. Compared to unvaccinated individuals, the Ct value was higher among individuals who had received one or two vaccine doses, but the Ct value decreased gradually with time since the second-dose vaccination. Ct value was 2.07 cycles higher (95% CI: 1.42-2.72) for those with a prior infection than those without prior infection. The Ct value was lowest among individuals tested because of symptoms and was highest among individuals tested as a travel requirement. Delta was substantially more infectious than Beta. Prior immunity, whether due to vaccination or prior infection, is associated with lower infectiousness of breakthrough infections, but infectiousness increases gradually with time since the second-dose vaccination.<\/jats:p>","DOI":"10.3389\/fimmu.2022.984784","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T05:42:30Z","timestamp":1663047750000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections"],"prefix":"10.3389","volume":"13","author":[{"given":"Suelen H.","family":"Qassim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad R.","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiam","family":"Chemaitelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houssein H.","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi M.","family":"Yassine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebah A.","family":"Al-Khatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria K.","family":"Smatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan F.","family":"Abdul-Rahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheyath K.","family":"Nasrallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ghaith","family":"Al-Kuwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullatif","family":"Al-Khal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imtiaz","family":"Gillani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anvar Hassan","family":"Kaleeckal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyazuddin Mohammad","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Nizar","family":"Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einas","family":"Al-Kuwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jeremijenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel A.","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bertollini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamad Eid","family":"Al-Romaihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Al-Thani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laith J.","family":"Abu-Raddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01836-w","article-title":"An early warning system for emerging sars-Cov-2 variants","volume":"28","author":"Subissi","year":"2022","journal-title":"Nat Med"},{"key":"B2","volume-title":"Tracking sars-Cov-2 variants","year":"2021"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003879","article-title":"Introduction and expansion of the sars-Cov-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study","volume":"18","author":"Abu-Raddad","year":"2021","journal-title":"PloS Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2110300","article-title":"National study group for covid epidemiology. efficacy of natural immunity against sars-Cov-2 reinfection with the beta variant","volume":"385","author":"Chemaitelly","year":"2021","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2200133","article-title":"Protection against the omicron variant from previous sars-Cov-2 infection","volume":"386","author":"Altarawneh","year":"2022","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1056\/NEJMoa2114114","article-title":"Waning of Bnt162b2 vaccine protection against sars-Cov-2 infection in Qatar","volume":"385","author":"Chemaitelly","year":"2021","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01583-4","article-title":"Bnt162b2 and mrna-1273 covid-19 vaccine effectiveness against the sars-Cov-2 delta variant in Qatar","volume":"27","author":"Tang","year":"2021","journal-title":"Nat Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1586\/14737159.5.2.209","article-title":"Basic principles of real-time quantitative pcr","volume":"5","author":"Arya","year":"2005","journal-title":"Expert Rev Mol Diagn"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001499","article-title":"Reporting of rt-pcr cycle threshold (Ct) values during the first wave of covid-19 in Qatar improved result interpretation in clinical and public health settings","volume":"71","author":"Coyle","year":"2022","journal-title":"J Med Microbiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.32.2001483","article-title":"Duration of infectiousness and correlation with rt-pcr cycle threshold values in cases of covid-19, England, January to may 2020","volume":"25","author":"Singanayagam","year":"2020","journal-title":"Euro Surveill"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.28.21252608","article-title":"Association between sars-Cov-2 transmissibility, viral load, and age in households","author":"Lyngse","year":"2021","journal-title":"medRxiv"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab421","article-title":"Sars-Cov-2 infectivity by viral load, s gene variants and demographic factors and the utility of lateral flow devices to prevent transmission","author":"Lee","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(20)30985-3","article-title":"Transmission of covid-19 in 282 clusters in Catalonia, Spain: A cohort study","volume":"21","author":"Marks","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa638","article-title":"Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples","volume":"71","author":"Bullard","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41467-022-28199-7","article-title":"Relative infectiousness of sars-Cov-2 vaccine breakthrough infections, reinfections, and primary infections","volume":"13","author":"Abu-Raddad","year":"2022","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taac068","article-title":"Effects of Ba.1\/Ba.2 subvariant, vaccination, and prior infection on infectiousness of sars-Cov-2 omicron infections","author":"Qassim","year":"2022","journal-title":"J Travel Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the Bnt162b2 mrna covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mrna-1273 sars-Cov-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"B19","unstructured":"National project of surveillance for variants of concern and viral genome sequencing. Qatar viral genome sequencing data. data on randomly collected samples2021"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.768883","article-title":"One year of sars-Cov-2: Genomic characterization of covid-19 outbreak in Qatar","volume":"11","author":"Benslimane","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.09.006","article-title":"Real-time sars-Cov-2 genotyping by high-throughput multiplex pcr reveals the epidemiology of the variants of concern in Qatar","volume":"112","author":"Hasan","year":"2021","journal-title":"Int J Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1038\/s41598-021-85428-7","article-title":"Characterizing the Qatar advanced-phase sars-Cov-2 epidemic","volume":"11","author":"Abu-Raddad","year":"2021","journal-title":"Sci Rep"},{"key":"B23","unstructured":"Planning and statistics authority-state of qatar. Qatar monthly statistics2020"},{"key":"B24","unstructured":"Taqpath\u2122 Covid\u221219 Ce\u2212Ivd Rt\u2212Pcr kit instructions for use2020"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2031364","article-title":"Persistence and evolution of sars-Cov-2 in an immunocompromised host","volume":"383","author":"Choi","year":"2020","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104684","article-title":"Two prolonged viremic sars-Cov-2 infections with conserved viral genome for two months","volume":"88","author":"Abu-Raddad","year":"2021","journal-title":"Infect Genet Evol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2104974","article-title":"Effectiveness of the Bnt162b2 covid-19 vaccine against the B.1.1.7 and B.1.351 variants","volume":"385","author":"Abu-Raddad","year":"2021","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01446-y","article-title":"Mrna-1273 covid-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe covid-19 disease in Qatar","volume":"27","author":"Chemaitelly","year":"2021","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.19623","article-title":"Association of prior sars-Cov-2 infection with risk of breakthrough infection following mrna vaccination in Qatar","volume":"326","author":"Abu-Raddad","year":"2021","journal-title":"JAMA"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/01632787211047932","article-title":"A systematic review of the protective effect of prior sars-Cov-2 infection on repeat infection","volume":"44","author":"Kojima","year":"2021","journal-title":"Eval Health Prof"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2022.112911","article-title":"Sars-Cov-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity","volume":"209","author":"Pilz","year":"2022","journal-title":"Environ Res"},{"key":"B32","volume-title":"Statistical software: Release 16.1","year":"2019"},{"key":"B33","unstructured":"Infection with the sars-Cov-2 delta variant is associated with higher recovery of infectious virus compared to the alpha variant in both unvaccinated and vaccinated individuals\n            LuoCH\n            MorrisCP\n            SachithanandhamJ\n            AmadiA\n            GastonDC\n            LiM\n          2021"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101129","article-title":"Transmission, viral kinetics and clinical characteristics of the emergent sars-Cov-2 delta voc in guangzhou, China","volume":"40","author":"Wang","year":"2021","journal-title":"EClinicalMedicine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jamainternmed.2021.7949","article-title":"Severity of illness in persons infected with the sars-Cov-2 delta variant vs beta variant in Qatar","volume":"182","author":"Butt","year":"2022","journal-title":"JAMA Intern Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab909","article-title":"Severity, criticality, and fatality of the sars-Cov-2 beta variant","volume":"75","author":"Abu-Raddad","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.chom.2021.06.006","article-title":"Sars-Cov-2 spike L452r variant evades cellular immunity and increases infectivity","volume":"29","author":"Motozono","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against sars-Cov-2 infection and covid-19 disease: Results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2119432","article-title":"Waning mrna-1273 vaccine effectiveness against sars-Cov-2 infection in Qatar","volume":"386","author":"Abu-Raddad","year":"2022","journal-title":"N Engl J Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00575-4","article-title":"Assessment of protection against reinfection with sars-Cov-2 among 4 million pcr-tested individuals in Denmark in 2020: A population-level observational study","volume":"397","author":"Hansen","year":"2021","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1825","article-title":"A meta-analysis on the role of children in severe acute respiratory syndrome coronavirus 2 in household transmission clusters","volume":"72","author":"Zhu","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0962-9","article-title":"Age-dependent effects in the transmission and control of covid-19 epidemics","volume":"26","author":"Davies","year":"2020","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00783-21","article-title":"Nasopharyngeal expression of angiotensin-converting enzyme 2 and transmembrane serine protease 2 in children within sars-Cov-2-Infected family clusters","volume":"9","author":"Hasan","year":"2021","journal-title":"Microbiol Spectr"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.984784\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T05:42:35Z","timestamp":1663047755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.984784\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,13]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2022.984784"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.984784","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.07.05.22277257","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,13]]},"article-number":"984784"}}